top of page
Writer's pictureDr. Ross Hanson

Neuropathy Relief With Laser Therapy


What is it?

Peripheral Neuropathy is nerve damage that occurs in the nerves that travel into the hands and feet. More than 20 million Americans have Peripheral Neuropathy which can cause chronic pain, numbness, weakness, tingling and balance issues.


What Causes It?

Neuropathy can come from a number of sources including diabetes, auto immune diseases, infections, exposure to chemicals, and trauma. Unfortunately, many cases are considered 'idiopathic' which means there is no known cause.



How Is It Treated?

Typical treatment includes drugs that many times do not help or come with too many unpleasant side effects.


If the conventional treatments have not helped, you should consider Laser Therapy.


Recent studies have shown that Laser Therapy is an effective treatment for Neuropathy without any of the side effects of drugs.


How Does Laser Therapy Work?

Laser Therapy promotes microcirculation in the irradiated area, increases nerve functional activity, increases the rate of axon growth and myelinisation and improves regeneration of the injured nerve.


Typically a series of Laser Therapy treatments will be prescribed with some additional at home adjuncts. Laser Therapy treatments are painless and each treatment typically takes about 10 minutes.


How Do I Know If It Will Help Me?

Not everyone will be a candidate for this treatment but you can contact me for a Neuropathy Qualification Evaluation to determine if this will help you. If you'd like to set up an appointment online CLICK HERE or call my office directly at 651-430-3229.


Dr. Hanson



Scientific Recources:


Low level laser therapy for the patients with painful diabetic peripheral neuropathy - A systematic review.


Efficacy of low level laser therapy on peripheral neuropathy in type 2 diabetes mellitus

7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015 Bengaluru, India


Biological Effects of Low Level Laser Therapy

J Lasers Med Sci. 2014 Spring; 5(2): 58–62.



408 views0 comments

Comments


bottom of page